SEC EDGAR Filing Information

Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]

Filing Date Changed: 2006-02-13
Documents: 1

SEC Accession No.
0000950162-06-000191
Filing date: 2006-02-13
Accepted: 2006-02-13 12:13:11

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13D/A	elandor13dano5_021306.htm	112969	ELAN/DOR SCHEDULE 13D/A NO. 5 - 02/13/06

		0000950162-06-000191.txt	115130	Complete submission text file

Filer Information:

ELAN CORP PLC (Filed by) (0000737572)
IRS No.: 000000000 | State of Incorp.: | Fiscal Year End: 1231
Type: SC 13D/A | Act: | Film No.:
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
TREASURY BUILDING
LOWER GRAND CANAL STREET
DUBLIN 2 L2 00000
35317094000

Mailing Address
TREASURY BUILDING
LOWER GRAND CANAL STREET
DUBLIN 2 L2 00000

DOR BIOPHARMA INC (Subject) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-39976 | Film No.: 06601773
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1691 MICHIGAN AVE.
SUITE 435
MIAMI FL 33139
305-534-3383

Mailing Address
1691 MICHIGAN AVE.
SUITE 435
MIAMI FL 33139